📰 Launch Dynamix News
Page 5 - Launch Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Launch Dynamix. Real-time updates on events, politics, business and more.
October 7, 2021
/PRNewswire/ -- At three months post-launch, the high expectations for Biogen/Eisais Aduhelm in Alzheimers disease have not quite materialized....
May 12, 2021
/PRNewswire/ -- Nephrologists have long considered chronic kidney disease (CKD) progression and diabetic kidney disease (DKD) as areas in dire need of new and...
March 12, 2021
/PRNewswire/ -- The Lupus Foundation of America estimates that 1.5 million Americans, and at least five million people worldwide, have a form of lupus.[1] As...
February 17, 2021
Share this article Share this article EXTON, Pa., Feb. 17, 2021 /PRNewswire/ -- Approved just two weeks apart in June of last year for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA), in-class competitors, Novartis Cosentyx and Eli Lillys Taltz, have since experienced rapid uptake. According to feedback from 97 US rheumatologists in the latest report included in Spherixs RealTime Dynamix ™ service, the official entrance of the IL-17 inhibitors is causing a shift in the ...
January 29, 2021
Spherix Global Insights Introduces New Service Focusing on Recent Launches in Expanding Immunology, Nephrology, and Neurology Markets The Launch Dynamix™ service includes current tracking of Cosentyx (Novartis) and Taltz (Eli Lilly) in non-radiographic axial spondyloarthritis, Kesimpta (Novartis) in multiple sclerosis, Stelara (Janssen) in ulcerative colitis, Tremfya (Janssen) in psoriatic arthritis, and Benlysta (GSK) and Lupkynis (Aurinia) in lupus nephritis News provided by Share this arti...